| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.91B | $2.84B | $2.53B |
| YoY Revenue Growth % | +2.4% | +12.4% | — |
| Gross Profit | $1.06B | $998.2M | — |
| Gross Margin % | 36.5% | 35.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $159.0M | $133.1M | $90.5M |
| Operating Margin % | 5.5% | 4.7% | 3.6% |
| Net Income (GAAP) | $30.6M | $25.0M | $41.6M |
| EBITDA (Normalized) | $194.0M | $148.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $291.0M | $142.9M | $81.0M |
| Capital Expenditures (CapEx) | $43.7M | $18.9M | — |
| Free Cash Flow (FCF) | $247.3M | $123.9M | $81.0M |
| FCF Margin % | 8.5% | 4.4% | 3.2% |
| Return on Invested Capital (ROIC %) | 6.3% | 6.8% | — |
| Cash & Short-Term Equivalents | $104.5M | $131.3M | — |
| Total Debt (Short + Long Term) | $1.33B | $1.35B | — |
| Total Stockholders' Equity | $758.4M | $331.7M | — |